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SPIEGEL and KOVACS observed a specific absorption at 265 mμ in C. S. F. from a 
patient of acute brain injury. From this, he claimed that there was an increase of nucleic 
acid in C. S. F. of these patients. SPIEGEL also prepared thin sections of a cat's spinal 
cord and added to them C, S. F. which was obtained from the patient who had head 
injury. These .;ections were incubated for a certain period and stained with NISSLE 
staining method. He noticed the disappearance of N1ssLE granules, chromatolysis, in the 
anterior horn cells and concluded that there occurred an increase of ribonuclease in 
C. S. F. after head injury. 
Thus, they believed that the nucleic acid determination in the C. S. F. would give 
us the best indication of estimating the degree of organic damage of the brain. 
In this experiment, the biochemical studies of similar line were carried out on 
〔.S. F from the various neurological and neurosurgical patients. 
METHOD 
C. S. F. obtained by lumbar puncture or ventricular tap. The fluid obtained was 
immediately kept in ice or dry ice and examined within 4 hours at the latest. 
To determine the maximum absorption, lcc of C. S. F. was diluted with Zee of 
distilled water and then the absorption curve between 240 mμ and 300 fi/.L of the ultra・ 
violet portion was obtained by D. U. BECKMAN’s spectrophotometer. 
For the identification of ascorbic acid in C. S. F., ascorbic acid oxidase was obtained 
from pumpkins through the purification according to the NELSON's method. When O.lcc 
of this enzyme containing solution was added to lcc of C. S. F., the absorption of 
川 corbicacid disappears completely within about 3 minutes. 
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In the determination of the ascorbic acid content in C. S. F., lee of仁.S. F. was 
diluted with Zee of 0.2 M citrate-phospate buffer (PH 5.7) and 0.1 cc of ascorbic acid 
oxidase was added. The decrease of optical density at 265 m1.c following oxidase reaction 
was interpreted as the amount of ascorbic acid. 
In the determination of ribonuclease activity in C. S. F., the absorption of ascorbic 
acid at 265 fi/J, was completely nullified first, and then ribonuclease activity was deter-
mined according to the KuNITZ' s method. 
RESULTS 
( 1 ) Ultravioletspectrum of C. S. F. 
Even in C. S. F. taken from the patients who were considered to be normal neuro-
logically, such cases as appendicitis, inguinal hernia, or hemorrhoids, the maximum absorp-
tion at 265 mμ was also noticPd. This opposed to the opinion of SPIEGEL or Kov ACS 
that the maximum absorption at 265 mμ was specifically present in C. S. F. of head 
injury patients. 
During the determination with D. U. BECKMAN spectrophotometer, though it was to 
a minor degree, it was found that the maximum absorption at 265 m '},decreased gradually 
as time passed. Since nucleic acid shows a very stable ultraviolet absorption at 260 mμ, 
it is quite unlikely that its absorption disappears in a short period of tim<>. 
( 2 ) Biochemical examination of the substance which has its maximum absorption at 
265 mμ. 
1 cc of C. S. F. from the head injury patient added with 0.2 cc of 60% perchloric 
acid was centrifuged with 5000 G at 0。cfor 5 minutes. The precipitate was dissolved 
into lcc of distilled water and the absorption curve in ultraviolet portion was obtained. 
The supernate was neutralized with 4N KOH to remove P. C. A. and centrifuged 
with 2500 G at 0。Cfor 5 minutes. The absorption curve of this supernate was also 
obtained. Neither in the supernate nor in the precipitate, absorption at 265 m1.c was 
found. C. S. F. taken from 40 patients of various neurosurgical cases were also studied 
by the uranyl acetate method, the absorption curve in ultraviolet portion revealed the 
same results both in the supernate and the precipitate. 
The absorption at 265 mμ disappeared immediately by adding CuSO』， FeCl2 and 
HgCb to C. S. F. When cysteine was added to the C. S. F. after the lumbar puncture, 
there found nearly no decrease in the maximum absorption. 
Judging from these experimental results, it is rather difficult to consider that the 
absorption at 265 m;J, is due to nucleic acid, and it is presumed that this may be due to 
ascorbic acid which has its maximum absorption at the same wave length. 
( 3 ) Identification of ascorbic acid in C. S. F. 
If nucleic acid of sizable amount exists in C. S. F., there should remain the absor-
ption at 260 mμ even after the removal of ascorbic acid. 
Then, to C. S. F. taken from the various cases such as, brain tumor. epilepsy, brain 
injury, cerebral vascular lesion and PARKINSON's disease, ascorbic acid oxydase was added. 
In no sample did the absorption reveal a peak at 260 m1.i. 
Though there noticed maximum absorption at 280mμ in C. S. F. from the brain 
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tumor cases or in xanthochromic C. S. F., this was probably due to protein. Because the 
protein determination made according to the FouN-CIOCALTEU's method revealed fairly 
high protein contents in these C. S. F. samples. 
Thus the maximum absorption at 265 m,u was proved to be due to ascorbic acid, and 
the decrease in absorption by incubation or other procedure should be explained by the 
autoxidative process of ascorbic acid. 
( 4 ) Ribonuclease in C. S. F. 
As mentioned above, SPIEGEL considered, through his histochemical study, that there 
was an increase of ribonuclease in C. S. F of a head『injurypatient. 
This problem was also investigated in the present study. 
Ribonuclease activity was relatively high even in C. S. F. of neurologically normal 
patients. In C S. F. from the cases of brain injury, epilepsy, diseases of extrapyramidal 
system and others, there was no marked increase of activity, the only exception appeared 
in cases of the xanthochromic cerebroepinal fluid, which showed high activity. 
These results were not accord to the histochmical determination of ribonuclease 
activity through the chromatolysis of the anterior horn cels of the spinal cord. 
( 5 ) Determination of ascorbic acid content in C. S. F. 
Since the absorption at 265 mμ of C. S. F. was proved not due to nucleic acid but 
ascorbic acid, ascorbic acid content of C. S. F. in various neurosurgical patients was 
determined. The patients were divided into following 5 groups neurologically normal 
cases, patients within a month from mild or moderate head injury, cases with posttraumatic 
complaints, those who had snbjective symptoms and passed over a month after the・ injury, 
brain tumor cases, and patients of other diseases. 
In each pathological group, the amount of ascorbic acid was lowered, comparing with 
the normal group, and the decrease in ascorbic acid was most remarkable in the group 
of cases with posttraumatic complaints, then getting les marked in the groups of brain 
tumor, other diseas白 andcases within a month after head injury, in this order. 
CONCLUSION 
1. UV absorption of C. S. F. at 265 mμ proved, through enzymatical study, to be 
due to ascorbic acid. 
2. On the basis of available evidences, spontaneous decrease in UV absorption of 
C. S. F. isnot due to degradation of nucleic acid but autoxidation of ascorbic acid. 
3. Content of RNase in C. S. F. from the patients of head injury was not increased 
as compared with that of the neurologically normal cases. 
4. Ascorbic acid of C. S. F. was decreased only in the patients with prolonged 








2. 髄液内 265mμ の紫外部吸収を示す物質の生
化学的同定















ーーすなわちP いわゆる hyperboliccurve－一 にーもど
ることも併せて報告している．（図 1) 
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J CL＇を とり p これに生理的食塩水2ccを加えて 3倍に
希釈し， 25'Ctこ解置して ~65111 .11 の吸収を時間的に追
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表 1 Su1rnnc1ryけtpurification procedure （ふ仁川illιacidoxidase) 
Total Spec1五c Specific 
Fraction volume Total 《lどt1v1tv 《iιt1v1t、 Recovery 
lmli um ts （山l山 ig ) (unit、／刊） 〔劣）dry 日刊日ht l】rote1n
1. Crude extract 640 1839.86 0.06 100 
2. (NH4 i/S0.1 fraction 
3. l¥eprecipit:itirn1、川th
115 215.280 1.10 1目300 12 1NH,12SCJ1 
-1. Elute from alumina 40 149.76 2.135 8 
1. 0 
酸化酸素O.lccを加え，室温に 7分解置する．その後
リボ核酸溶液 1ccを加え， 23c 2時閥解宣したのちP
Mac Fadyen試薬2ccを加えさらに 23℃ 30分解置す
る．ついで遠.e,、分離をおこないその上清について 260
k ¥ 7 I ¥ mμ の紫外部吸収を測定した．そのさい260m11におけ
ハ＼ ／ ｜ ＼ る吸光度の 0.1の上昇を l単｛立とした．なお基質とし
~ 0.61 ¥"-./ I ¥ 
] 0.4↓ ¥ ! ¥ じて，氷酢酸による沈澱法を数回くりカミえすことによ
ξ I ＼，~min ::t::id：~：it ：。n ＼ つて精製しP ヌク Lオチドy オリゴヌクレオチドの混
o. 2ト ＼～一一’－－－－－－－－－・－－－－－.ご＼ 在していない事をたしかめた．このリボ核酸を酢酸緩
0 ' ' ' ' ［一六 慨（0.1モ＇＼. pH 5.0）でO九に溶解し舗とした．
' 
240 250 260 270 280 290 300 アスコルピン酸の定量にあたってIi，腰椎穿刺より












討した結果， 0.2そルのクエン酸ーリン酸緩衝液m r pH
5.7）迫らもっとも目的にかなった緩衝液となり得るこ
とを予備実験でたしかめこれを採用した．すなわちP












' No. and distribution of maxima at wave 
Total No. ：一」E盟t_~丘
Diagnosis of sample , 265 
ド i 260 270 275 280 285 : 2?. 
Type I 
Acute stage : I ' I 
Chronic stage i I ! 
i , Acute sta11e 7 i 
!Type E ロ




i 1 Acute stage i 2 ; 1 1 
!Type][' ' I ! Chr口町 stage ! 2 ~ I I 
Subarachnoidal bleeding i 2 , I I 
Arterio-venous malformation 5 ! 5 
1 Aneurysma : 2 i 2 
Spasmodic torticolis i 2 ' I 1 
E山a~d;l disease : Par!《in
L三山官to羽s ｜ L一一一L一一一Undiagno剖削rolgκaldise蹴 I 8 , 8 
一一一子urologicallynormal : 5 r - 4 1← 
Glioma ' 3 I 3 
Men叩 m l s I 2 3 
Pituitary tumor 1 3 i I 
1I -Ventricle tumor 1 I ' 1 
Brain tumor 
Multiple myeloma I ' I 
Metastatic tumor ' I 
Epilepey ' 6 1 5 
Cerebral palsy ! I ' 
Brain absc巴S i I 
M阻cellaneous Arachno 
disease Cervical strain syndrび『ne I 2 2 
Trigeminal neuralgia 1 I 
Radiculitis ' I 
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Wove len~th (mμ) 
3 Effect of incubation 

























① 265mμ よりも 267mμ に最大吸収を示すものが
比較的多い．














°J. I.Ob I ml of CSF L一、
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Effect of added adenine 
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1 m I of CS F ( 1 ) 
中add.O. 2 ml of 60唱PCA
PPt1. ( 2) Sup. 〆山 t"pH 7. 0 
with 4N KOH 
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図 6
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I ml of CSF + O.OJml of 0.1 MC¥き＂＂＇町
(mixed during lumbulpuncture) 
2ηi of dis water 
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傷後l力月以内の症例〔8名）では，全症例正常範囲

























ピン酸含有量はp 正＇＂；；；か p むしろ正常より，~い、値を示
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